Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Goodman syndrome is an extremely rare genetic disorder characterized by marked malformations of the head and face (essentially acrocephaly), abnormalities of the hands and feet (polydactyly, syndactyly, clinodactyly, camptodactyly, ulnar deviation), and congenital heart disease. There have been no further descriptions in the literature since 1979. Goodman syndrome could be a variant of Carpenter syndrome.
Biomarker and diagnostic research for Goodman syndrome has been reported in the published literature.
No clinical trials have been registered for Goodman syndrome.
125 publications have been identified in PubMed for Goodman syndrome. Kisho has analyzed 89 by research type. Research spans Clinical Trial Publication (36%), Review / Meta-Analysis (21%), and Epidemiology / Natural History (16%).
Research Type | Count | % of Total |
|---|---|---|
Clinical study results | 32 | 36% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 12:49 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Goodman syndrome
Research summaries
19 |
21% |
Disease patterns and progression | 14 | 16% |
Laboratory research | 13 | 15% |
New treatment approaches | 5 | 6% |
Testing and diagnosis research | 3 | 3% |
Other research | 2 | 2% |
Patient case studies | 1 | 1% |
Campanale A (2026). [PMID: 41386393](https://pubmed.ncbi.nlm.nih.gov/41386393/). *Prog Neuropsychopharmacol Biol Psychiatry*. [Basic Science / Preclinical]
Butler CC (2026). [PMID: 42019019](https://pubmed.ncbi.nlm.nih.gov/42019019/). *N Engl J Med*. [Clinical Trial Publication]
Dlugos DJ (2026). [PMID: 41133912](https://pubmed.ncbi.nlm.nih.gov/41133912/). *Epilepsia*. [Clinical Trial Publication]
Jacobs JP (2026). [PMID: 40744347](https://pubmed.ncbi.nlm.nih.gov/40744347/). *Clin Gastroenterol Hepatol*. [Clinical Trial Publication]
Jha SK (2026). [PMID: 32491719](https://pubmed.ncbi.nlm.nih.gov/32491719/). *Unknown Journal*. [Clinical Trial Publication]
Goodman BP (2026). [PMID: 41526146](https://pubmed.ncbi.nlm.nih.gov/41526146/). *Handb Clin Neurol*. [Review / Meta-Analysis]
Keele BF (2026). [PMID: 41617893](https://pubmed.ncbi.nlm.nih.gov/41617893/). *Nat Microbiol*. [Gene Therapy / Novel Therapeutics]
Sorin M (2026). [PMID: 41448213](https://pubmed.ncbi.nlm.nih.gov/41448213/). *Lancet Haematol*. [Review / Meta-Analysis]
Jukema JW (2026). [PMID: 42185072](https://pubmed.ncbi.nlm.nih.gov/42185072/). *Eur Heart J*. [Diagnostic / Biomarker]
Plebon-Huff S (2026). [PMID: 41908777](https://pubmed.ncbi.nlm.nih.gov/41908777/). *Front Public Health*. [Epidemiology / Natural History]